The global synovial sarcoma market is characterized by rising demand due to a surge in diagnoses of this rare cancer. Major players are focusing on researching new therapies to treat this aggressive {condition|. The market is projected to expand at a substantial CAGR over the forecast period. Numerous factors are contributing this growth, including